RE:RE:RE:Re:Dear Hydro...this is up for discussion..Option 3, sit tight, weather the storm. Current acquistion costs are too high, reference ACB/CMED and APH/NUU. Perhaps near legalization or 3rd quarter the landscape will be clearer. Money is king right now, if THCX spends it and something unpredictable happens, such as delayed legalization, then there could be trouble without the reserves. There are going to be a number of desperate companies without enough revenue to survive long term, these guys will be on the cheap. Very unlikely there will be any '3 baggers' until the US changes its federal laws and the big pharma, tobacco, alcohol, banks come calling. These are the only ones who could afford the high acquisition costs. Canopy could afford THCX, but is now clearly developing distribution agreements with suppliers going forward as their strategy seems to be the largest drug dealer on the planet....